Detalles de la búsqueda
1.
Distress: Characterizing What Causes the Thermometer to Shift in Patients with Newly Diagnosed Breast Cancer Attending a Multidisciplinary Clinic.
Ann Surg Oncol;
26(10): 3204-3209, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31342366
2.
Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer.
BMC Cancer;
19(1): 1036, 2019 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31675929
3.
Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer.
BMC Cancer;
16: 274, 2016 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-27090210
4.
Phase II Trial of Five-Fraction Accelerated Partial Breast Irradiation (APBI) Using Noninvasive Image-Guided Breast Brachytherapy (NIBB).
Int J Radiat Oncol Biol Phys;
2023 Dec 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38151190
5.
Axillary ultrasound and fine-needle aspiration in the preoperative evaluation of the breast cancer patient: an algorithm based on tumor size and lymph node appearance.
AJR Am J Roentgenol;
195(5): 1261-7, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20966338
6.
Phase 2 Trial of Accelerated Partial Breast Irradiation (APBI) Using Noninvasive Image Guided Breast Brachytherapy (NIBB).
Int J Radiat Oncol Biol Phys;
108(5): 1143-1149, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32721422
7.
Five fraction accelerated partial breast irradiation using noninvasive image-guided breast brachytherapy: Feasibility and acute toxicity.
Brachytherapy;
17(5): 825-830, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29936130
8.
The rationale, technique, and feasibility of partial breast irradiation using noninvasive image-guided breast brachytherapy.
Brachytherapy;
13(5): 493-501, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24997723
9.
Frequent pathologic complete responses in aggressive stages II to III breast cancers with every-4-week carboplatin and weekly paclitaxel with or without trastuzumab: a Brown University Oncology Group Study.
J Clin Oncol;
27(28): 4693-700, 2009 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19720916
Resultados
1 -
9
de 9
1
Próxima >
>>